Perth-based drug discovery company Phylogica has signed an agreement with pharmaceuticals maker Roche to evaluate Phylogica's proprietary Phylomer technology in transporting large molecules to attack disease targets within cells.
18/12/2009 - 15:03
Phylogica signs Roche deal
18/12/2009 - 15:03
